CSF3 and acute myeloid leukemia: Homoharringtonine-based protocols, such as homoharringtonine, Ara-C, and G-CSF (HAG) and homoharringtonine, Ara-C, and aclarubicin (HAA), appear to be more effective and better tolerated than intensive chemotherapy in the treatment of adult RR-AML [39–43].